FDA Import Refusal 112-1503714-7/1/1 — Laboratoire Glaxosmithkline

Laboratoire Glaxosmithkline — FEI 3003513196

The FDA refused shipment 112-1503714-7/1/1 from Laboratoire Glaxosmithkline (France) on Aug 22, 2008. The refused product falls under Drugs and Biologics — NARATRIPTAN TABLETS (ANALGESIC). Cited charge: 75

Refusal details

Date
Aug 22, 2008
Country
France
Product Category
Drugs and Biologics
Product Code
60LCA86 NARATRIPTAN TABLETS (ANALGESIC)
Charges
75

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.